Research programme: autoimmune disease therapeutics - Inimmune
Latest Information Update: 08 Dec 2023
At a glance
- Originator Inimmune
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders
Most Recent Events
- 06 Oct 2023 Early research in Autoimmune disorders in USA (unspecified route) prior to October 2023 (Inimmune pipeline, October 2023)